BioHorizons' $88 million initial public offering (IPO) is scheduled to begin February 3, 2011, according to a story in the Wall Street Journal and other news reports. Shares in the dental implant maker are expected to sell for around $16 apiece.
In addition to dental implants, BioHorizons manufactures tissue-regeneration products for the replacement of missing teeth. Its implant products are based on a proprietary Laser-Lok platform technology and biomechanically engineered threads.
The company believes that its proprietary Laser-Lok platform technology is the only technology on the market today for which clinical data support reduced bone and soft-tissue loss, analysts said.
Copyright © 2011 DrBicuspid.com
